$17.60
1.29% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
CH1242303498
Symbol
OCS
Sector
Industry

Oculis Stock price

$17.60
-0.52 2.87% 1M
+2.69 18.04% 6M
+0.60 3.53% YTD
+5.61 46.79% 1Y
+7.44 73.23% 3Y
+7.44 73.23% 5Y
+7.44 73.23% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.23 1.29%
ISIN
CH1242303498
Symbol
OCS
Sector
Industry

Key metrics

Market capitalization $844.80m
Enterprise Value $640.42m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 4.98
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-88.52m
Free Cash Flow (TTM) Free Cash Flow $-59.25m
Cash position $205.63m
EPS (TTM) EPS $-2.65
P/E forward negative
P/S forward 884.26
EV/Sales forward 670.33
Short interest 0.04%
Show more

Is Oculis a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Oculis Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Oculis forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Oculis forecast:

Buy
100%

Financial data from Oculis

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs 0.51 0.51
50% 50%
-
-0.51 -0.51
50% 50%
-
- Selling and Administrative Expenses 25 25
24% 24%
-
- Research and Development Expense 63 63
64% 64%
-
-88 -88
50% 50%
-
- Depreciation and Amortization 0.51 0.51
50% 50%
-
EBIT (Operating Income) EBIT -89 -89
50% 50%
-
Net Profit -116 -116
74% 74%
-

In millions USD.

Don't miss a Thing! We will send you all news about Oculis directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Oculis Stock News

Neutral
GlobeNewsWire
11 days ago
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:00 p.m. CEST / 9:00 a.m. EDT.
Neutral
GlobeNewsWire
11 days ago
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:00 p.m. CEST / 9:00 a.m. EDT.
Neutral
GlobeNewsWire
12 days ago
ZUG, Switzerland, May 08, 2025 (GLOBE NEWSWIRE) -- The recent R&D Day ( replay ) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor's (OCS-05) positive results from the ACUITY trial in Acute Optic Neuritis OCS-01: DIAMOND Ph3 trials enrollmen...
More Oculis News

Company Profile

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improve eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.

Head office Switzerland
CEO Riad Sherif
Employees 49
Founded 2016
Website oculis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today